Becker's Healthcare January 19, 2022
Katie Adams

Google partnered with the University of California Santa Cruz Genomics Institute to create an artificial intelligence-powered method that accelerates genome sequencing data analysis for faster disease detection.

The method, called the PEPPER-Margin-DeepVariant, analyzes data for Oxford Nanopore sequencers, one of the fastest commercial sequencing technologies available, according to a Jan. 13 company blog post.

On Jan. 12, the New England Journal of Medicine published a study led by the Stanford (Calif.) University School of Medicine demonstrating the method’s use in a newborn intensive care unit. The method was used to analyze genomic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Technology, Trends
Digital Innovation Plus AI Tech Can Future-Proof the Enterprise
The AI frenzy could fall flat as companies hoard chips without enough data centers to host them
New AI drug discovery powerhouse Xaira rises with $1B in funding
EU regulation: AI Act will mean a raft of new requirements for ‘high-risk’ systems
Why nurses are protesting AI

Share This Article